Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anisha B Patel

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
Dermatology Online Journal|September 17, 2020
Dermatomyositis associated with nivolumab therapy for melanoma: a case report and review of the literatureAlison Messer, Brandy Drozd, Isabella C Glitza, et al.
JAAD Case Reports|November 25, 2024
A retrospective case series of eight patients with epidermal growth factor receptor inhibitor-induced cutaneous toxicities managed with dupilumabFiorinda F Muhaj, Jessica Tran, Julia Dai, et al.
The Oncologist|August 29, 2022
In ReplyMario E Lacouture, Anisha B Patel, Jonathan E Rosenberg, et al.
Frontiers in Allergy|March 20, 2023
Mucocutaneous adverse events to immune checkpoint inhibitorsFiorinda Muhaj, Padmavathi V Karri, Wylie Moody, et al.
BMC Dermatology|April 18, 2015
Photoallergic reaction in a patient receiving vandetanib for metastatic follicular thyroid carcinoma: a case reportJennifer Goldstein, Anisha B Patel, Jonathan L Curry, et al.
Dermatology Online Journal|February 23, 2018
Erythema multiforme major in a patient with metastatic melanoma treated with nivolumabSwami Sundaresan, Kathleen T Nguyen, Kelly C Nelson, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 21, 2021
Cutaneous Surgery Outcomes in Patients on Epidermal Growth Factor Receptor InhibitorsMichelle A Robinson, Anisha B Patel, Kelly M Wilmas, et al.
Dermatology Online Journal|July 2, 2020
A case of new-onset vitiligo in a patient on tofacitinib and brief review of paradoxical presentations with other novel targeted therapiesJulie K Nguyen, Megan J Schlichte, Reena Jogi, et al.
The Lancet. Oncology|May 2, 2024
When leukaemia masquerades: the hidden syphilis diagnosisMeryl Musicante, Julianna Martel Harrell, Shelby Kubicki, et al.
Cancer Treatment and Research Communications|January 6, 2022
A retrospective chart review of management strategies for lichenoid eruptions associated with immune-checkpoint inhibitor therapy from a single institutionWylie M Masterson, Alexandria M Brown, May A Al Ameri, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Dermatology Online Journal|September 17, 2020
Dermatomyositis associated with nivolumab therapy for melanoma: a case report and review of the literatureAlison Messer, Brandy Drozd, Isabella C Glitza, et al.
JAAD Case Reports|November 25, 2024
A retrospective case series of eight patients with epidermal growth factor receptor inhibitor-induced cutaneous toxicities managed with dupilumabFiorinda F Muhaj, Jessica Tran, Julia Dai, et al.
The Oncologist|August 29, 2022
In ReplyMario E Lacouture, Anisha B Patel, Jonathan E Rosenberg, et al.
Frontiers in Allergy|March 20, 2023
Mucocutaneous adverse events to immune checkpoint inhibitorsFiorinda Muhaj, Padmavathi V Karri, Wylie Moody, et al.
BMC Dermatology|April 18, 2015
Photoallergic reaction in a patient receiving vandetanib for metastatic follicular thyroid carcinoma: a case reportJennifer Goldstein, Anisha B Patel, Jonathan L Curry, et al.
Dermatology Online Journal|February 23, 2018
Erythema multiforme major in a patient with metastatic melanoma treated with nivolumabSwami Sundaresan, Kathleen T Nguyen, Kelly C Nelson, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 21, 2021
Cutaneous Surgery Outcomes in Patients on Epidermal Growth Factor Receptor InhibitorsMichelle A Robinson, Anisha B Patel, Kelly M Wilmas, et al.
Dermatology Online Journal|July 2, 2020
A case of new-onset vitiligo in a patient on tofacitinib and brief review of paradoxical presentations with other novel targeted therapiesJulie K Nguyen, Megan J Schlichte, Reena Jogi, et al.
The Lancet. Oncology|May 2, 2024
When leukaemia masquerades: the hidden syphilis diagnosisMeryl Musicante, Julianna Martel Harrell, Shelby Kubicki, et al.
Cancer Treatment and Research Communications|January 6, 2022
A retrospective chart review of management strategies for lichenoid eruptions associated with immune-checkpoint inhibitor therapy from a single institutionWylie M Masterson, Alexandria M Brown, May A Al Ameri, et al.
Pageof 9